Энтеродез

Quick links to important sections

Энтеродез

Selected form

Treatment option: Dysentery

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Энтеродез

Quick Facts

Property Description
Active ingredient Povidone-Iodine (PVP-I)
Form Aqueous Solution or Powder for Solution
Pharmacological class Antiseptic and Germicide (Iodophor)
Common use Microbial Disinfection and Infection Prevention
Origin Synthetic (Polymer-Iodine Complex)

What Type of Medicine is Энтеродез?

Энтеродез is a potent pharmaceutical preparation classified as an antiseptic and germicide, whose primary function is to neutralize microorganisms. Its active component is Povidone-Iodine (PVP-I), a substance clinically recognized for its reliable efficacy and included on the World Health Organization List of Essential Medicines. The drug is formally designated to the pharmacological class of iodophors, which are specialized complexes designed to carry and stabilize elemental iodine.

Composition and Origin: Is Povidone-Iodine a Synthetic Complex?

The core active substance, Povidone-Iodine, is defined as a synthetic compound resulting from the stable chemical complexation of the disinfectant iodine with the polymer Polyvinylpyrrolidone (PVP). This product, Энтеродез, is specifically positioned for topical administration, typically formulated as an aqueous solution or provided as a powder for solution. The PVP polymer acts as an inert, water-soluble carrier, facilitating the controlled release of free iodine (I2) at the application site. The development of iodophors, such as this complex, offers enhanced germicidal stability compared to traditional iodine preparations.

What is the General Purpose of This Broad-Spectrum Antiseptic?

The general purpose of Энтеродез is to achieve effective disinfection and mitigate the potential for infection by rapidly eliminating a wide range of harmful microorganisms. For example, it is typically used for general skin preparation before minor procedures. The underlying physiological action relies on the released iodine causing oxidation of cellular components and iodination of proteins within pathogens. This decisive mechanism grants the preparation a broad antimicrobial spectrum, making it effective against numerous bacteria, viruses, fungi, and protozoans. This robust capability supports the fundamental therapeutic goal of ensuring microbial control at the intended site of application.

Regulatory References

  1. World Health Organization List of Essential Medicines
  2. NIH

What side effects are possible with Энтеродез?

Possible side effects and safety information

The safety characteristics of Povidone-Iodine (Энтеродез) are formally organized in regulatory documents, classifying potential reactions into local effects and rare systemic concerns related to iodine absorption.

Local reactions are frequently categorized as Rare, including local irritation, minor skin burns, and hypersensitive skin reactions like erythema or small blisters. Anaphylactic reactions, which are more serious, are typically documented as Uncommon.

Systemic Safety Concerns

The most significant high-level safety concerns stem from systemic iodine uptake, particularly following long-term use or application over large surface areas. These effects are grouped into Endocrine System Disorders and Renal and Urinary Disorders.

  • Endocrine Effects: Potential for iodine-induced thyroid dysfunction, including hypothyroidism or hyperthyroidism. This risk is heightened for patients with pre-existing thyroid conditions.
  • Serious Reactions: Officially documented serious adverse reactions include anaphylactic shock, acute renal failure, and metabolic acidosis in cases of extensive systemic absorption.

Population-Specific Constraints

Specific populations are noted in safety documentation due to increased risk. Neonates and small infants are at a higher risk of developing transient hypothyroidism. Large amounts of Povidone-Iodine should not be administered to pregnant or breastfeeding women, as iodine can cross the placenta and enter breast milk, potentially affecting the newborn’s thyroid function. Use is contraindicated in individuals with known hypersensitivity to iodine or pre-existing hyperfunction of the thyroid (hyperthyroidism).

The safety profile confirms that most concerns relate to systemic exposure, emphasizing the distinction between mild, local effects and rare, but significant, internal system disorders.

Overdose and Emergency Response

Overdose involving Povidone-Iodine, the active component in Энтеродез, is officially documented to present with corrosive gastrointestinal effects, including vomiting, abdominal symptoms, and potential for bloody diarrhoea. Systemic manifestations may include fever, delirium, stupor, and seizures. Regulator-listed physiological abnormalities include metabolic acidosis, hypernatraemia, and severe electrolyte imbalance. Overdose can lead to life-threatening outcomes such as circulatory collapse, shock, and acute renal failure, including anuria. Laryngeal and pulmonary edema are also recognized severe complications.

The regulatory mandate is to seek immediate medical attention and contact emergency services or a poison control center immediately upon known or suspected excessive exposure. Treatment is officially defined as symptomatic and supportive. No specific antidote is known to be available for iodine poisoning. Management procedures include continuous monitoring of vital signs, mental status, and laboratory values such as renal function, liver function, and electrolyte balance. Population-specific warnings exist, noting the increased risk of hypothyroidism in neonates and the need for iodine level monitoring in patients with pre-existing renal impairment.

Therapeutic Uses of Энтеродез

What Энтеродез Treats: Main Uses and Benefits

The core purpose of Энтеродез (Povidone-Iodine) is derived from its role as a broad-spectrum antiseptic, which is commonly applied to help reduce the microbial load on the skin and mucous membranes. The substance is relevant across domains due to its broad activity against a range of pathogens, which informs its therapeutic applications.

This antiseptic is primarily used in situations involving certain distressing symptoms and applied across domains where additional symptomatic support is needed. It plays a role in managing microbial populations across conditions presenting with acute episodes and those characterized by periods of heightened symptoms. These therapeutic areas include antiseptic first aid for minor skin injuries and trauma, microbial control for high-risk clinical and chronic wounds, and localized management of mucosal irritation.

The medication helps address symptom clusters that may become intense or disruptive in scenarios where short-term symptomatic assistance is needed. For patients, this provides support that helps ease the overall symptom burden: “The supportive microbial control may assist the body’s natural recovery process from injury and irritation.” Through its application in these contexts, it assists with maintaining functional stability by supporting general well-being during symptomatic phases.


Quick Fact: Relief for Localized Symptoms
Энтеродез is commonly used to help manage symptoms related to inflammatory or irritative states arising from microbial activity on skin breaks, mucous membranes, or surgical sites.

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Энтеродез

Regulatory documentation defines strict guidelines for the use of Энтеродез (Povidone), primarily based on contraindications and the availability of safety data in specific populations.

Contraindicated Populations (Must Not Use):

  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to the active substance, povidone (polyvinylpyrrolidone), or any other component in the medicine's formulation.
  • Age Restriction: Children under 1 year of age (infants) are explicitly contraindicated.

Restricted Use Populations (Not Recommended):

  • Pregnancy and Lactation: Use during pregnancy and the breastfeeding period is generally not recommended or contraindicated. This restriction is due to a lack of established, sufficient safety data from controlled studies in these vulnerable populations, rather than confirmed definitive harm.

Eligible Populations:

  • The medicine is officially eligible for use in adults and children aged 1 year and older, provided they do not have any of the specific contraindications listed above.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The active ingredient in Enterodez, Povidone, is an enterosorbent. Its official interaction profile is characterized by a single, non-systemic mechanism: the physical binding of substances within the gastrointestinal tract. This mechanism leads to clinically significant interactions with other orally administered products.


Official Regulatory Interaction Profile

Interaction Type Regulatory Statement
Exposure Modification Co-administration with any orally administered medicinal product is documented to result in a reduction in that product's absorption and systemic exposure.
Mechanistic Basis Pharmacokinetic interaction via physical adsorption; no documented interactions involving CYP enzymes or drug transporters.
Timing-Based Rules A strict temporal separation is required. Other oral medications must be administered at least 1 hour before or 2 hours after taking Enterodez to mitigate the risk of therapeutic failure.
Food/Substance Interactions Concurrent administration with food or beverages (other than water) is restricted to maintain the drug’s binding capacity.

Interaction Context

The primary constraint noted in official labeling is procedural: the requirement to strictly adhere to the dosing time separation. Failure to observe this rule can compromise the effectiveness of co-administered treatments. No specific medicinal products are listed as absolutely contraindicated, as the interaction is managed by temporal spacing.

Mechanism of Action

The mechanism of action for Энтеродез (Povidone-Iodine) is defined by a rapid, non-specific chemical attack on microbial cells, resulting in the elimination of microorganisms at the application site through multi-site molecular destruction.

️ Irreversible Chemical Destruction of Microbial Cellular Components

This domain involves the release of free molecular iodine (I2), the active species, which executes a non-selective oxidation and iodination of critical microbial targets. The mechanism chemically modifies proteins (structural and enzymatic) and nucleic acids within pathogens, simultaneously leading to their rapid denaturation and functional collapse. The multi-site attack causes cellular failure across multiple microbial types. The mechanism of simultaneous, non-selective targeting of core structures contributes to the absence of acquired resistance.

️ Metabolic Collapse and Carrier-Mediated Sustained Action

The destructive chemical interactions lead to the irreversible inactivation of essential cytosolic enzymes, specifically those involved in the TCA cycle and respiratory chain, resulting in the immediate arrest of cellular energy production (ATP synthesis). Mechanistically, the Polyvinylpyrrolidone (PVP) polymer acts as an inert carrier, controlling the release of the active iodine. This unique delivery system ensures a prolonged duration of biocidal action in the localized microenvironment. This controlled release mitigates the caustic effect associated with uncomplexed iodine. The resulting prolonged biocidal action is a direct physiological consequence of the unique iodophor structure.

Dosage and Administration Information

Instruction Map: How to use Энтеродез — Official Administration Guidelines

Administration of Povidone-Iodine (the active substance of Энтеродез) is governed by specific external and localized protocols established in standardized protocols. These instructions define the standardized use across different approved forms.

Feature Detail
Route of administration Primarily Topical/Cutaneous (for skin and wound application), Oromucosal (for gargle/rinse forms), and Ophthalmic (for pre-procedural preparation).
Dosing schedule For minor topical application, a small amount of the 10% solution or ointment is applied to the affected area. For oromucosal use, a designated volume (e.g., 10 mL) of the 0.5% gargle solution is used full strength.
Frequency pattern As-needed for first aid use, typically applied 1 to 3 times daily. Pre-procedural use (e.g., ophthalmic prep) is generally a single application.
Preparation requirements Topical solutions are typically applied undiluted. Ophthalmic preparation protocols require the residual solution to be flushed from the eye using a sterile saline solution after the designated contact time.
Age-group administration rules Topical use in children under 12 years of age requires consultation. The oromucosal gargle solution is explicitly restricted for use in children under 12 years of age.

Resulting Procedural Structure

The established usage protocols structure the medicine into defined external courses:

  • The area of application must be cleansed before the product is applied.
  • The antiseptic must be allowed to dry completely before any bandage or sterile dressing is applied over the site.
  • Oromucosal forms must be gargled for the specified duration and spat out; swallowing the solution is prohibited.

Connection to the Overall Use Protocol Standard guidelines limit the product to short-term use, defining the maximum course duration as no longer than seven consecutive days for self-medication across most formulations, ensuring adherence to the intended localized, non-systemic application protocols.

Recent Clinical Evidence

Overview of Research Findings

Энтеродез, chemically Povidone or Polyvinylpyrrolidone (PVP), is a water-soluble polymer that is the primary component in some oral detoxifying agents and a carrier for iodine in many topical antiseptic preparations (Povidone-Iodine, or PVP-I).

Research regarding the oral application of PVP has explored its function as an adsorbent (a substance that binds to other substances). Early studies investigated its use in reducing the duration and severity of symptoms associated with various gastrointestinal disturbances and intoxications, including those of infectious and non-infectious origin. The proposed action involves the binding and removal of toxins and harmful metabolites from the digestive tract.


Clinical Outcomes and Tolerability

Most available clinical evidence focuses on Povidone's role as the carrier component in Povidone-Iodine (PVP-I) topical solutions, particularly for surgical site antisepsis, wound management, and ophthalmology, where its broad-spectrum antimicrobial activity is assessed.

Area of Research Key Study Focus (PVP-I)
Antisepsis Reduction of microbial load pre- and post-surgery; prevention of surgical site infections (SSIs).
Wound Care Efficacy in the management of acute and chronic wounds, often compared against other antiseptic agents.

Studies generally report that the use of Povidone-Iodine is associated with low rates of local irritation, though adverse effects such as skin irritation, mild burning sensations, or temporary discoloration may occur upon application. Research on various formulations, including gels and drops, continues to investigate the safety and effects across different medical applications, including the potential for alleviating dry eye symptoms with specific Povidone formulations.

Frequently Asked Questions (FAQ)

Common questions about Энтеродез (FAQ)


Q: Is it possible for Энтеродез to interact with vitamins or supplements?

A: Yes, official documents state that this product, as an oral adsorbent, can physically bind to any substance taken by mouth, including vitamins and supplements. This binding can potentially reduce the amount of that substance absorbed by the body. Regulatory guidance suggests that a time separation be observed (e.g., taking other products at least 1 hour before or 2 hours after) to mitigate this potential risk.

Q: Can Энтеродез be taken with antibiotics?

A: The main interaction risk noted in regulatory labeling is that Энтеродез can reduce the absorption of other oral medications, such as antibiotics. Due to its physical binding mechanism in the gastrointestinal tract, the product may compromise the effectiveness of co-administered treatments. Therefore, regulatory guidance suggests observing a strict temporal separation, typically at least 1 hour before or 2 hours after, to manage this interaction.

Q: Can people with kidney problems use Энтеродез?

A: Official safety documentation advises caution regarding the use of this product in individuals with impaired renal (kidney) function. Because the iodine component can be absorbed systemically with extensive use, its excretion can be compromised. For this reason, official safety information indicates that use is generally considered contraindicated for individuals who have impaired renal function.

Q: Can Энтеродез affect the absorption of birth control pills?

A: Official product labeling indicates that taking this product close to the time of other oral medicines, including birth control pills, may reduce their absorption. This is due to the physical binding action of the adsorbent in the gastrointestinal tract. Regulatory guidance suggests a strict time separation be observed (e.g., 1 hour before or 2 hours after) to help manage the risk of reduced effectiveness.

Q: Is it true that Энтеродез can bind toxins in the stomach?

A: Yes, official mechanism of action descriptions classify the product as a physical adsorbent. Its purpose is to bind toxins and harmful metabolites throughout the entire gastrointestinal tract, which begins in the stomach. This physical binding helps remove these unwanted substances from the body.

Q: Is the active substance in Энтеродез absorbed into the bloodstream?

A: The Povidone polymer component of the enterosorbent is generally considered non-absorbable by the body and passes through the digestive tract. However, the iodine component, which can be present in some formulations, has the potential for systemic absorption. This risk is documented to be associated with extensive, long-term use.

Q: Do studies suggest any long-term effects from using Энтеродез?

A: Regulatory documents explicitly restrict the use of this product to a short-term duration, typically no longer than seven consecutive days for self-medication. This restriction is intended to minimize the potential risk of systemic effects associated with prolonged use. The safety profile confirms that most significant concerns relate to systemic exposure from non-adherence to this time limit.

Q: What is the shelf life of Энтеродез?

A: The dry powder formulation is typically manufactured for long-term stability, often several years, when stored properly in its original container. However, official information specifies that once the powder is prepared into a solution, its stability is limited. The reconstituted liquid should be refrigerated and is typically advised to be discarded if not used within three days.

Q: Does Энтеродез cause constipation or diarrhea?

A: Official adverse event reports do not typically list constipation as a common side effect of normal use. While the active ingredient has been studied as a countermeasure against diarrhea, diarrhea itself is only noted in regulatory toxicology reports as a symptom associated with accidental swallowing of excessive amounts (overdose).

Q: Is there a specific time of day Энтеродез should be taken?

A: Regulatory dosing instructions do not mandate a specific time of day for administration (such as morning or night). The official dosing schedule for general use is typically described as being 'as needed' or one to three times daily, depending on the specific approved use protocol.

Q: Are there any warnings for elderly people using Энтеродез?

A: Official regulatory labeling specifically addresses the elderly population. It states that the medicine is not expected to cause different side effects or problems in this age group than it does in younger adults. No specific warnings unique to older adults are mandated in the core safety sections of the drug’s labeling.

Q: Is Энтеродез a prescription or an over-the-counter medicine?

A: Official protocols and usage guidelines refer to the product in the context of 'self-medication' and first aid use for a short duration. This general guidance indicates that the product is typically categorized as an over-the-counter (OTC) medicine.

Q: Can a person with diabetes use Энтеродез?

A: While diabetes is not listed as a contraindication, regulatory warnings for the iodine component note the potential for test interference. Official warnings note this potential interference, which may be a relevant safety consideration if using a topical formulation on a test site, as it can cause false readings on point-of-care glucometers.

Q: What happens if someone misses a time when they were supposed to use Энтеродез?

A: Official dosing guidance usually states that a missed dose should be administered as soon as possible if remembered. However, if it is almost time for the next scheduled use, the guidance often advises skipping the missed dose and resuming the regular schedule.

Q: Can Энтеродез affect laboratory blood test results?

A: The iodine component of the product is documented in regulatory warnings as having the potential to interfere with certain laboratory tests. Specifically, there is data indicating that it can cause false readings on point-of-care blood glucose monitors if the test site is not properly cleansed after topical application.

Q: What is the primary way the body removes the active ingredient in Энтеродез?

A: The main Povidone polymer, acting as an enterosorbent, is not absorbed and is removed from the body primarily via feces. Any iodine component that is absorbed systemically with prolonged or extensive use is removed by the kidneys.

How should Энтеродез be stored and disposed of?

How to Store and Dispose of Энтеродез?

The storage requirements for Энтеродез (Povidone) differ for the dry powder and the reconstituted solution, as specified in regulatory documentation. The dry powder must be stored in a dry place, protected from light, at a temperature between -10 C and +30 C. This medicine must also be stored in a location that is explicitly out of the sight and reach of children.

Stability and Disposal

The labeled shelf life of the reconstituted oral solution is limited. The solution must be stored under refrigeration at +4 C and must be discarded if not used within three days of preparation. Official guidance mandates that unused or expired portions must be disposed of in accordance with local regulations, and the substance should not be released into the environment, such as drains or surface water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Энтеродез found in:

A-Z Index: